Estonia-based Better Medicine raises nearly $7 million to expand its radiology AI solution and enter the U.S. market.
Key Details
- 1Better Medicine is an AI startup focused on radiology, founded in 2020 in Estonia.
- 2The company raised an additional $1.2 million, bringing total funding close to $7 million.
- 3Its flagship product, BMVision Kidney, detects malignant lesions from CT scans.
- 4Better Medicine currently operates in six countries and aims to expand to the U.S.
- 5The new funding will support further European growth and preparations for U.S. market entry.
Why It Matters
Better Medicine's growth and international expansion reflect ongoing investor confidence in radiology AI. Tools that integrate into radiologist workflows and target specific organs, such as the kidney, could enhance cancer detection and address radiologist shortages globally.
Source
Radiology Business
Related News
•AuntMinnie
Radiologists Struggle to Spot AI-Generated Radiology Images
Radiologists correctly identify AI-generated images 75% of the time, with CT and MRI images being particularly challenging to spot.
•Radiology Business
Framework Assesses Real-World Financial Impact of Radiology AI Adoption
A new analysis presents a financial calculator for objectively assessing the return on investment (ROI) of implementing radiology AI solutions.
•Radiology Business
Study Finds Disparities in Access to Stroke Imaging AI Tools
Research shows access to AI stroke detection tools is concentrated in resource-rich hospitals despite Medicare incentives.